GLP results coming up which are already de risked and then we move into phase 1 and Walter reed which is derisked from 2012 pre clinical study then FDA submission in Feb and then phase 2 with funding from the US defence force.You have made every single thing up.
The US Army aren't paying for a stage 2 trial. Christ alive, Walter Mitty would turn in his grave.
FDA submission??
What are you submitting mate - do you know?
I'll tell you - you are asking them for permission to do a human trial. An IND application.
You are not de-risked. I don't know why I'm bothering as all you do is keep repeating the same silly things over and over again.
https://www.fda.gov/media/82381/download
You are at stage 1 of 12 steps
It clearly states:
Trial cohort numbers
Stage 1 - 100 patients
Stage 2 - 300 patients
Stage 3 - 1000+ patients.
You are at the very beginning of the FDA journey, and as I've pretty much shown you to be a bloke that has absolutely no idea what he's talking about, I'll leave this here.
To everyone else - here is the journey ahead - you are at Stage 1 on a 12 step journey that will take 10+ years.
Please read THESE: https://www.fda.gov/media/82381/download
It takes 10 years minimum from where Nyrada is now to gain approval - often longer:
https://lifesciences.n-side.com/blog/what-is-the-average-time-to-bring-a-drug-to-market-in-2022
Lastly - you know how many drug start-ups that fund these trials themselves?
1 in 1000 - yes, that's all - 0.01%
You aren't going any further on this journey without a big pharma company. You are about $200,000,000 short of funds.
Best result would be a 50% share of the company in exchange for trial funding.
Worst - they buy you out when the SP is at rock bottom.
AGN has nothing to do with this.
$10,000,000 in the bank has nothing to do with this.
Read the FDA info mate and stop telling porkies to people - you have absolutely no idea what you are talking about, and some people here seem to think you do. You don't.
- Forums
- ASX - By Stock
- NYR
- Ann: Nyrada Commences Walter Reed Traumatic Brain Injury Study
NYR
nyrada inc.
Add to My Watchlist
2.94%
!
33.0¢

Ann: Nyrada Commences Walter Reed Traumatic Brain Injury Study, page-55
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
33.0¢ |
Change
-0.010(2.94%) |
Mkt cap ! $69.60M |
Open | High | Low | Value | Volume |
34.0¢ | 34.3¢ | 32.5¢ | $195.9K | 589.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 14970 | 33.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
33.5¢ | 20100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 14970 | 0.330 |
3 | 41398 | 0.325 |
2 | 77000 | 0.320 |
2 | 96590 | 0.315 |
8 | 104200 | 0.310 |
Price($) | Vol. | No. |
---|---|---|
0.335 | 20100 | 1 |
0.340 | 76361 | 2 |
0.345 | 56182 | 2 |
0.350 | 22442 | 3 |
0.355 | 24064 | 1 |
Last trade - 15.29pm 25/07/2025 (20 minute delay) ? |
Featured News
NYR (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online